Cell Biotech Co. Ltd (049960) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.033x

Based on the latest financial reports, Cell Biotech Co. Ltd (049960) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.15 Billion ≈ $2.81 Million USD) by net assets (₩127.11 Billion ≈ $86.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cell Biotech Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Cell Biotech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 049960 total debt and obligations for a breakdown of total debt and financial obligations.

Cell Biotech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cell Biotech Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
GlycoNex TWO:4168	-0.017x
Pinar Entegre Et ve Un Sanayi AS IS:PETUN	-0.017x
UOB Kay Hian Securities (Thailand) Public Company Limited BK:UOBKH	0.148x
Empress Royalty Corp V:EMPR	0.029x
Compass Digital Acquisition Corp NASDAQ:CDAQ	0.037x
AAC Clyde Space AB (publ) ST:AAC	-0.034x
GrandTech C.G. Systems TWO:6123	-0.014x
Mobix Labs Inc NASDAQ:MOBX	-1.021x

Annual Cash Flow Conversion Efficiency for Cell Biotech Co. Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Cell Biotech Co. Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 049960 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩124.17 Billion ≈ $84.15 Million	₩19.27 Billion ≈ $13.06 Million	0.155x	+122.14%
2023-12-31	₩111.89 Billion ≈ $75.82 Million	₩7.82 Billion ≈ $5.30 Million	0.070x	-41.08%
2022-12-31	₩108.09 Billion ≈ $73.25 Million	₩12.81 Billion ≈ $8.68 Million	0.119x	-15.07%
2021-12-31	₩106.69 Billion ≈ $72.30 Million	₩14.89 Billion ≈ $10.09 Million	0.140x	+45.93%
2020-12-31	₩99.98 Billion ≈ $67.76 Million	₩9.56 Billion ≈ $6.48 Million	0.096x	-3.14%
2019-12-31	₩103.60 Billion ≈ $70.21 Million	₩10.23 Billion ≈ $6.93 Million	0.099x	-25.37%
2018-12-31	₩105.62 Billion ≈ $71.58 Million	₩13.98 Billion ≈ $9.47 Million	0.132x	-47.02%
2017-12-31	₩90.20 Billion ≈ $61.12 Million	₩22.53 Billion ≈ $15.27 Million	0.250x	+16.83%
2016-12-31	₩84.15 Billion ≈ $57.03 Million	₩17.99 Billion ≈ $12.19 Million	0.214x	-19.39%
2015-12-31	₩68.76 Billion ≈ $46.60 Million	₩18.24 Billion ≈ $12.36 Million	0.265x	+40.17%
2014-12-31	₩52.36 Billion ≈ $35.48 Million	₩9.91 Billion ≈ $6.71 Million	0.189x	-9.37%
2013-12-31	₩43.05 Billion ≈ $29.17 Million	₩8.99 Billion ≈ $6.09 Million	0.209x	+23.25%
2012-12-31	₩36.42 Billion ≈ $24.68 Million	₩6.17 Billion ≈ $4.18 Million	0.169x	-1.36%
2011-12-31	₩31.77 Billion ≈ $21.53 Million	₩5.45 Billion ≈ $3.70 Million	0.172x	--

About Cell Biotech Co. Ltd

KQ:049960 Korea Biotechnology & Medical Research

Market Cap

$83.71 Million

₩123.52 Billion KRW

Market Cap Rank

#19860 Global

#1129 in Korea

Share Price

₩16000.00

Change (1 day)

-1.42%

52-Week Range

₩11500.00 - ₩16550.00

All Time High

₩56579.38